BioGaia AB (publ) (STO:BIOG.B)
127.70
-3.80 (-2.89%)
May 26, 2026, 5:29 PM CET
BioGaia AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 871.78 | 801.31 | 1,224 | 1,544 | 1,488 | 1,485 |
Cash & Short-Term Investments | 871.78 | 801.31 | 1,224 | 1,544 | 1,488 | 1,485 |
Cash Growth | -30.22% | -34.53% | -20.74% | 3.75% | 0.25% | 1.15% |
Accounts Receivable | - | - | 189.77 | 105.88 | 130.7 | 118.59 |
Other Receivables | - | - | 32.35 | 33.32 | 18.73 | 36.3 |
Total Trade Receivables | - | - | 222.12 | 139.19 | 149.44 | 154.89 |
Inventory | - | - | 152.89 | 181.2 | 142.84 | 102.74 |
Other Current Assets | 444.05 | 417.76 | 11.19 | 9.85 | 16.84 | 9.77 |
Total Current Assets | 1,316 | 1,219 | 1,610 | 1,874 | 1,797 | 1,752 |
Net Property, Plant & Equipment | 176.83 | 181.15 | 205.62 | 213.33 | 157.73 | 153.64 |
Other Intangible Assets | 0.63 | 0.7 | 0.77 | 46.23 | 46.08 | 48.09 |
Goodwill | 151.53 | 146.5 | 175.1 | 165.17 | 171.52 | 149.23 |
Long-Term Investments | 28.01 | 28.01 | 28.01 | 28.01 | 25.79 | 22.23 |
Other Long-Term Assets | 21.81 | 22.37 | 14.32 | 6.01 | 15.38 | 2.8 |
Total Assets | 1,695 | 1,598 | 2,034 | 2,333 | 2,214 | 2,128 |
Accounts Payable | - | - | 48.3 | 49.31 | 32.05 | 42.31 |
Accrued Expenses | - | - | 101.32 | 86.36 | 77.95 | 56.4 |
Unearned Revenue | - | - | 8.84 | 8.53 | 9.17 | 2.82 |
Other Current Liabilities | - | - | 47.75 | 51.53 | 45.83 | 25.43 |
Total Current Liabilities | 266.49 | 199.14 | 206.2 | 195.74 | 164.99 | 126.95 |
Other Long-Term Liabilities | 4.96 | 4.96 | 103.87 | 107.11 | 76.56 | 123.73 |
Total Long-Term Liabilities | 20.58 | 79.49 | 103.87 | 107.11 | 76.56 | 123.73 |
Total Liabilities | 287.06 | 278.63 | 310.07 | 302.85 | 241.55 | 250.69 |
Common Stock | - | - | 20.23 | 20.2 | 20.2 | 20.2 |
Additional Paid-in Capital | - | - | 1,174 | 1,153 | 1,154 | 1,154 |
Accumulated Other Comprehensive Income | - | - | 38.5 | 15.94 | 25.7 | -0.03 |
Retained Earnings | - | - | 491.04 | 840.83 | 772.73 | 703.19 |
Total Common Shareholders' Equity | 1,403 | 1,314 | 1,724 | 2,030 | 1,972 | 1,877 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity | 1,403 | 1,314 | 1,724 | 2,030 | 1,972 | 1,877 |
Total Liabilities & Equity | 1,695 | 1,598 | 2,034 | 2,333 | 2,214 | 2,128 |
Net Cash (Debt) | 871.78 | 801.31 | 1,224 | 1,544 | 1,488 | 1,485 |
Net Cash Growth | 8.79% | -34.53% | -20.74% | 3.75% | 0.25% | 1.15% |
Net Cash Per Share | 8.62 | 7.92 | 12.11 | 15.29 | 14.74 | 14.70 |
Book Value | 1,403 | 1,314 | 1,724 | 2,030 | 1,972 | 1,877 |
Book Value Per Share | 13.87 | 12.99 | 17.06 | 20.11 | 19.53 | 18.59 |
Tangible Book Value | 1,250 | 1,167 | 1,548 | 1,819 | 1,755 | 1,680 |
Tangible Book Value Per Share | 12.36 | 11.54 | 15.32 | 18.01 | 17.38 | 16.64 |
Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.